Table 2 Association between per 10-point increment CVH score and the risk of cancer in male and female

Overall

0.97 (0.96–0.98) ^c

0.96 (0.95–0.97) ^c

Oral

0.82 (0.76–0.88) ^c

0.83 (0.75–0.93) ^c

Esophageal

0.71 (0.66–0.77) c

0.89 (0.79–1.01)

EAC

0.69 (0.64–0.76) ^c

0.78 (0.64–0.95) ^a

ESCC

0.78 (0.65–0.94) ^a

1.07 (0.9–1.27)

Stomach

0.79 (0.72–0.86) ^c

0.93 (0.82–1.07)

Small intestine

0.86 (0.72–1.03)

1.03 (0.85–1.24)

Colorectal

0.86 (0.83–0.89) ^c

0.94 (0.9–0.97) ^b

Anus

0.95 (0.75–1.2)

1.01 (0.83–1.21)

Liver

0.64 (0.58–0.7) ^c

0.83 (0.72–0.95) ^b

HCC

0.57 (0.51–0.64) ^c

0.78 (0.57–1.05)

CAC

0.8 (0.68–0.95) ^a

0.85 (0.72-1) ^a

Pancreatic

0.84 (0.78–0.91) ^c

0.84 (0.77–0.91) ^c

Laryngeal

0.66 (0.56–0.76) ^c

1.09 (0.51–2.32)

Lung

0.67 (0.64–0.7) ^c

0.7 (0.67–0.73) ^c

SCLC

0.65 (0.57–0.73) ^c

0.65 (0.58–0.73) ^c

NSCLC

0.68 (0.65–0.72) ^c

0.72 (0.68–0.76) ^c

Melanoma skin

1.08 (1.06–1.1) ^c

1.09 (1.07–1.11) ^c

Mesothelioma

1.03 (0.91–1.15)

0.97 (0.77–1.22)

Soft tissue

0.99 (0.85–1.16)

0.94 (0.83–1.07)

Breast

0.91 (0.71–1.17)

0.94 (0.92–0.96) ^c

Uterine

NA

0.8 (0.76–0.84) ^c

Ovarian

NA

0.99 (0.93–1.06)

Prostate

1.05 (1.03–1.07) ^c

NA

Kidney

0.82 (0.77–0.87) ^c

0.79 (0.72–0.86) ^c

RCC

0.84 (0.78–0.9) ^c

0.79 (0.72–0.87) ^c

TCC

0.77 (0.59-1) ^a

0.72 (0.5–1.04)

Bladder

0.79 (0.73–0.85) ^c

0.91 (0.8–1.03)

Brain

0.95 (0.87–1.05)

1.04 (0.93–1.17)

Thyroid

0.93 (0.78–1.12)

0.98 (0.88–1.1)

Lymphoma

1.01 (0.95–1.07)

1.03 (0.97–1.1)

HL

0.9 (0.71–1.13)

0.91 (0.71–1.16)

NHL

1.03 (0.96–1.09)

1.07 (1-1.15) ^a

Multiple myeloma

0.99 (0.91–1.09)

0.96 (0.86–1.06)

Leukemia

0.96 (0.89–1.03)

0.99 (0.9–1.08)